BrainInsight
510(k) K220815
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK220815 | Date19 Jul 2022 | StatusActive |
Official records
- FDA 510(k) database K220815
From the FDA record
- Received by the FDA
- 21 Mar 2022
- FDA decision
- 19 Jul 2022 (Substantially Equivalent)
- FDA review time
- 120 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QIH
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2050
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 23 Sep 2026
BrainInsight is a device classified under the Radiology advisory committee. It received a traditional 510(k) clearance as substantially equivalent to a predicate device.
The device was manufactured by Hyperfine, Inc. and cleared under K220815. It is authorized for distribution in the United States with FDA 510(k) clearance.
Similar devices
Other devices filed under FDA product code QIH (Automated Radiological Image Processing Software).
- Synapse PACS (7.6.0) by FUJIFILM Healthcare Americas Corporation
- RealGUIDE by 3DIEMME SRL
- Overjet Charting Assist by OVERJET
- DIANA by Ropca A/S
- Syngo Carbon Clinicals (VA41) by Siemens Healthineers AG
- Cleerly LABS (v2.0) by CLEERLY, INC
- OptimMRI by Rebrain, Sas
- Sonix Health by Ontact Health Co., Ltd.
- Viz HDS, Viz Volume Plus, Viz ICH+ by Viz.ai
- Artificial Intelligence Renal Assessment (AIRA) Version 1 by Aramis Global AI Consultancies, LLC